Digital Therapeutics Resources

The role of digital therapeutics, software that delivers clinical benefits and prevents, manages, and treats medical conditions, has evolved in the past few years. These products may be used independently or in tandem with other therapies to optimize clinical outcomes for patients and close gaps in care.  Further, patients can self-manage these therapies, or they can be managed under the direction of a clinician. As innovative therapies are introduced into the market, challenges with developing evidence-based coverage criteria and tracking utilization have been identified.  

These AMCP, AMCP Learn, and Journal of Managed Care + Specialty Pharmacy resources can help payers better evaluate, cover, and implement digital therapeutics.

AMCP Resources and Continuing Education

• AMCP Summit: Deep Dive into Prescription Digital Therapeutics 
  June 1, 2023
  As part of AMCP’s strategic priorities, AMCP will continue to encourage the exchange of ideas among stakeholders and initiate solutions that optimize patients’ health outcomes and address barriers to access to care. As part of this initiative, AMCP convened a summit to bring together thought leaders to discuss digital therapeutics and share their novel, unique perspectives with managed care professionals. 
• The Evolving Role of Digital Therapeutics — Proceedings from the AMCP Partnership Forum
  April 2022  
  This forum identified challenges and payer needs related to the evidence for digital therapeutics' place in therapy, monitoring or utilization metrics, and barriers that patients face in obtaining therapies 
  • Press Release | Executive Summary | Webinar | Forum Proceedings
• Prescription Digital Therapeutics
  The Access to Prescription Digital Therapeutics Act of 2023 is an important bipartisan bill that will improve care for millions of Americans by expanding coverage of prescription digital therapeutics. 
  • Issue Brief | Letter of Support | Press Release | Take Action
• Prescription Digital Therapeutics: Regulatory Approval Pathway and Outcomes Evidence
  May 2022–December 2023  

  The digital therapeutics market is rapidly growing, with thousands of digital therapeutics products now available. This rise brings the need for health plans to develop formulary strategies and coverage determinations for these products. 

  This online continuing pharmacy education program is accessible on AMCP Learn and offers 1.25 contact hours. AMCP Member Fee: Free. Non-Member Fee: Free.  

Journal of Managed Care + Specialty Pharmacy (JMCP) 

• Ensuring Public Trust in Digital Therapeutics: A Pharmacopeial Perspective
  April 2021
  How do quality and trust apply when the medicine is in a software or digital-only format? Digital therapeutics, an emerging modality, offers the potential to help patients prevent, manage, and treat physical, mental, and behavioral conditions.

• Decision-Makers Need an Approach To Determine Digital Therapeutic Product Quality, Access, and Appropriate Use
  April 2021
  As clinicians and managed care decision-makers increasingly encounter and review digital therapeutics for use in patient care, it is critical for industry stakeholders to develop a harmonized approach to DTx evaluation. 

• The Effectiveness and Value of Digital Health Technologies as an Adjunct to Medication-Assisted Therapy for Opioid Use Disorder
  April 2021
  Digital health technologies offer the potential to expand the availability of behavioral therapies and reduce costs. We examine the evidence for 3 such promising digital health technologies in this review: reSET-O, Connections, and DynamiCare.